Analyst Bullish on Cynosure (CYNO) Acquisition of PMTI (PMTI)

Go back to Analyst Bullish on Cynosure (CYNO) Acquisition of PMTI (PMTI)

Maxim Group Downgrades Palomar Medical Technologies (PMTI) to Hold

March 19, 2013 9:16 AM EDT

Maxim Group downgraded Palomar Medical Technologies (NASDAQ: PMTI) from Buy to Hold.

For an analyst ratings summary and ratings history on Palomar Medical Technologies click here. For more ratings news on Palomar Medical Technologies click here.

Shares of Palomar Medical Technologies closed at $13.17 yesterday, with a 52 week range of $7.06-$13.42.... More

Cynosure (CYNO) to Acquire Palomar Medical (PMTI) for $13.65/Share

March 18, 2013 7:25 AM EDT

Cynosure, Inc. (Nasdaq: CYNO) and Palomar Medical Technologies, Inc. (Nasdaq: PMTI) today announced that they have signed a definitive agreement, pursuant to which Cynosure will acquire Palomar in a cash and stock transaction valued at approximately $294 million.

Palomar shareholders will receive $13.65 per share of Palomar common stock: $6.825 per share in cash and $6.825 per share in Cynosure common stock (subject to adjustment and collar provisions described in the definitive agreement). Cynosure will issue approximately 5.2 million shares in the transaction and fund the approximately $147 million in cash... More